Sarcoma / 2015 / Article / Fig 4

Research Article

Phase II Trial of Gemcitabine and Docetaxel with Bevacizumab in Soft Tissue Sarcoma

Figure 4

Duration on study for each patient treated with gemcitabine + docetaxel + bevacizumab. Patients marked by stars discontinued treatment on study because of good response and elected to have surgery.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.